A Suite of Tests Optimized for Primary Detection and Surveillance
Cxbladder comes as a family of three products each optimized for a specific point along the patient journey.
Designed for patients presenting with hematuria, Cxbladder Triage analyzes the presence of five biomarker genes alongside information on known bladder cancer risk factors like age, gender and smoking history to rule out patients with a low risk of having the disease, reducing the need for further invasive procedures.
In cases where a patient is symptomatic and bladder cancer looks likely, Cxbladder Detect can help confirm your diagnosis. By detecting and quantifying signs of cancer at the molecular level, Cxbladder Detect outperforms other urine-based tests, making it an ideal choice for bladder cancer testing when patients present with significant symptoms. Cxbladder Detect can also be used as an adjunct to cystoscopy or as a substitute for other radiological tests to improve overall detection accuracy.
Developed specifically for patients undergoing surveillance for recurrent bladder cancer, Cxbladder Monitor combines clinical information linked to previous bladder cancer with measured biomarker genes to help rule out the presence of a recurrent tumour, or to indicate that further clinical investigation is required.
Cxbladder Monitor can provide accurate results with a single urine sample, and test is often used as a non-invasive monitoring alternative to reduce the frequency of cystoscopy required.
Download our Clinician Brochure